|Mr. Abe Schwartz||Chairman & Advisor||162.72k||N/A||N/A|
|Mr. Brian E. Pedlar||Chief Exec. Officer, Pres & Director||442k||N/A||N/A|
|Mr. Danny Brannagan||Chief Financial Officer||134.53k||N/A||N/A|
|Ms. Kim Crooks||VP of Operations||172.76k||N/A||N/A|
|Mr. John Hands||Exec. VP & VP - Marketing||161.83k||N/A||N/A|
Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical products in the areas of advanced wound care, infection management, and surgical procedures worldwide. The company offers Collagen Matrix platform to develop products for the treatment of donor and graft sites, traumatic and surgical wounds, and first and second degree burns, as well as diabetic, pressure, and venous ulcers; Antimicrobial Silicone Adhesive platform, a pre-surgical, post-surgical, and vascular access products; and medical coating platform CovaCoat, a technology that provides photochemical process for covalently linking coating molecules to various medical device surfaces. Its medical coatings deliver infection control, therapeutic delivery, and lubricity. The company also provides services, such as feasibility studies, product formulation, prototype testing, validation, regulatory clearances, and manufacturing. In addition, it offers wound care products comprising ColActive Plus Ag collagen matrix dressings; ColActive Transfer wound contact layers; and CovaWound advanced wound care dressings. Further, the company provides IV Clear and SurgiClear antimicrobial silicone dressings. It offers its technologies, products, and services to medical device companies; healthcare providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians offices; and individual consumers. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Covalon Technologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.